Sun Pharmaceutical Industries Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
4/10
|
40.31 | 59.52 | -32.28% | 44.67 | -9.76% |
| P/S |
|
8.08 | 9.3 | -13.11% |
|
|
| P/BV |
|
5.75 | 6.59 | -12.7% |
|
|
| P/FCF |
|
27.38 | -113.16 | -124.2% |
|
|
| Ev/Ebitda |
|
27.47 | 141.59 | -80.6% |
|
|
| Ev/S |
|
7.96 | 9.54 | -16.57% |
|
|
| Ev/FCF |
|
38.26 | -86.13 | -144.42% |
|
|
| E/P |
|
0.0352 | 0.1116 | -68.46% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
28.97 | 5.76 | 402.75% | 26.12 | +10.9% |
| ROE |
|
16.01 | 10.54 | 51.92% |
|
|
| ROA |
|
11.52 | 7.51 | 53.44% |
|
|
| ROIC |
|
18.08 | 16.06 | 12.6% |
|
|
| ROS |
|
20.05 | -4.21 | -576.05% |
|
|
| ROCE |
|
16.81 | 13.01 | 29.19% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.2366 | 121.74 | -99.81% | 0.3326 | -28.87% |
| Nеt Debt/Ebitda |
|
-0.4345 | 121.47 | -100.36% |
|
|
| Debt/Ratio |
|
0.0383 | 0.1451 | -73.59% |
|
|
| Debt/Equity |
|
0.2736 | 0.7224 | -62.13% |
|
|
| Debt/Net Income |
|
0.3418 | 5.06 | -93.25% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
2/10
|
0.7986 | 9.06 | -91.18% | 0.8959 | -10.86% |
| Number of years of dividend growth |
|
6 | 1.01 | 492.77% | ||
| DSI |
|
1 | 0.8335 | 19.98% |
|
|
| Average dividend growth |
|
28.19 | 3.39 | 731.92% |
|
|
| Average percentage for 5 years |
|
0.8959 | 15.05 | -94.05% |
|
|
| Average percentage for payments |
|
21.72 | 23.82 | -8.84% |
|
|
| Difference from average difference in sector |
|
-8.26 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
6/10
|
47.74 | 26.87 | 77.67% | ||
| Growth impulse Ebitda in 5 years |
|
84.1 | 461.6 | -81.78% | ||
| Growth impulse Net Income in 5 years |
|
154.36 | 28.21 | 447.18% | ||
| Growth impulse FCF in 5 years |
|
98.16 | -56.18 | -274.72% | ||
| Growth impulse EPS in 5 years |
|
137.58 | -57.24 | -340.36% |
IP Score
6.94/10
